Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study

Abstract

Asthma control; Lung function; Pediatric asthmaControl del asma; Función pulmonar; Asma pediátricaControl de l'asma; Funció pulmonar; Asma pediàtricaResearch sponsored by Sanofi and Regeneron Pharmaceuticals Inc. ClinicalTrials.gov Identifier: NCT02948959. Medical writing/editorial assistance was provided by Natalia Crespo, PhD, of Excerpta Medica, and was funded by Sanofi and Regeneron Pharmaceuticals Inc., according to the Good Publication Practice guidelines: 2022 update

    Similar works